ArticleClinics (Sao Paulo, Brazil)2026
Efficacy of glutamine supplementation in postoperative patients undergoing hepatic surgery: a systematic review and meta-analysis of randomized controlled trials.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe efficacy and safety of glutamine supplementation in patients receiving hepatic surgery remain controversial.
methodsA search strategy incorporating the terms "glutamine", "liver transplantation", and "hepatectomy" was applied across eight literature databases. Study quality was evaluated via the Risk of Bias 2.0 (ROB 2.0) tool, while statistical analyses were undertaken through R 4.4.1.
results18 studies involving 1198 patients were encompassed. Meta-analysis revealed that immune factors Immunoglobulin A (IgA), Immunoglobulin M (IgM), Cluster of Differentiation 3 (CD3), Cluster of Differentiation 4 (CD4), and CD4/Cluster of Differentiation 8 (CD8) were significantly higher in the glutamine cohort than those in the control cohort(SMD = 1.21, 0.25, 1.52, 0.99, and 0.77). Levels of inflammatory markers C-Reactive Protein (CRP), Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Interleukin-8 (IL-8) were markedly lower in the glutamine group (SMD = -2.03, -3.29, -1.86, -2.20, and -2.29). The glutamine cohort also exhibited a significant decrease in liver function indicators Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) (SMD = -1.03 and -1.05), while Cholinesterase (CHE) levels were significantly elevated (SMD = 0.61). Serum protein levels, including Albumin (ALB), Prealbumin (PA), and Total Protein (TP), were significantly higher in patients receiving glutamine (SMD = 0.68, 1.09, and 0.81). In addition, Adverse Events (AEs), defined as overall postoperative complications, were significantly less frequent in the glutamine group (RR = 0.59, 95% CI 0.44‒0.79).
conclusionGlutamine supplementation in postoperative hepatic surgery patients enhances immune function, reduces inflammation, improves liver function, and decreases the incidence of AEs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.